Upcom­ing HERA call under EU4Health – Next-Gen­er­a­tion Influen­za Vac­cines

The Euro­pean Health Emer­gency Pre­pared­ness and Response Author­i­ty (HERA) has announced a new call for pro­pos­als under the EU4Health pro­gram, aimed at enhanc­ing Europe’s pre­pared­ness against health threats. This fund­ing oppor­tu­ni­ty focus­es on accel­er­at­ing the devel­op­ment of next-gen­er­a­tion influen­za vac­cines. With a sig­nif­i­cant bud­get allo­ca­tion, this ini­tia­tive seeks to fos­ter inno­va­tion in med­ical coun­ter­mea­sures, strength­en pub­lic health strate­gies, and ensure faster respons­es to emerg­ing health crises.

Researchers, biotech firms, and health­care stake­hold­ers are encour­aged to sub­mit their pro­pos­als before the dead­line.

Mul­ti­ple Sourc­ing Frame­work Con­tracts to Speed up the Devel­op­ment of and Access to Inno­v­a­tive Med­ical Coun­ter­mea­sures: Next-Gen­er­a­tion Influen­za Vac­cines

Scope: This call for ten­ders seeks to accel­er­ate the devel­op­ment of next-gen­er­a­tion, rapid­ly scal­able influen­za vac­cines with inno­v­a­tive pro­duc­tion plat­forms, nov­el admin­is­tra­tion routes, broad pro­tec­tion against pan­dem­ic influen­za A virus­es, and intrin­sic immuno­genic­i­ty, through a phased Pre-Com­mer­cial Pro­cure­ment process. This is a com­pet­i­tive pro­ce­dure with nego­ti­a­tion with a max­i­mum con­tract dura­tion of 98 months.

Dead­line for receipt of requests to par­tic­i­pate: 19.5.2025 15:00 Europe/Brussels

Esti­mat­ed total val­ue: EUR 225Mio (per ser­vice con­tract estab­lished = phase 1 – EUR 12.95Mio, Phase II – EUR 35Mio (esti­mate), and Phase III – EUR 100Mio (esti­mate) – see ‘ten­der spec­i­fi­ca­tions’ doc­u­ment)

Read more: Next-gen­er­a­tion Influen­za Vac­cine F&Ts Appli­ca­tion Web­page

Source: Busi­ness Fin­land
Image: Chokni­ti Khongchum